Archer DX


Blood Cancer

Archer® Blood Cancer tests detect various driver mutations in hematologic malignancies, such as myeloid and lymphoid diseases, by targeted next-generation sequencing (NGS). This approach combines FusionPlex® and VariantPlex® panels to characterize gene fusions, copy number variations (CNVs) and other variants from a single sample.

Read More »
Solid Tumor

Archer® Solid Tumor tests provide a targeted sequencing approach to detect various driver mutation types in solid tumors. This approach combines FusionPlex®, VariantPlex® and LiquidPlex™ panels to characterize gene fusions, CNVs and other variants from a single, low-input FFPE sample and liquid biopsy.

Read More »

This website stores cookies on your computer. These cookies are used to improve your website and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy.

We won’t track your information when you visit our site. But in order to comply with your preferences, we’ll have to use just one tiny cookie so that you’re not asked to make this choice again.